Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three cases.

导出原文传递

翻译打印收藏纠错

第一作者： Elda,Mimiola

第一单位： Section of Hematology, Multidisciplinary Outpatients Clinics for Mastocytosis, Department of Medicine, AOUI, Verona, Italy.;Department of Immunohematology and Transfusion Medicine, ASST, Mantova, Italy.

作者： Elda,Mimiola ^[1] ; Riccardo,Bomben ^[2] ; Giovanna,De Matteis ^[3] ; Omar,Perbellini ^[4] ; Paola,Guglielmelli ^[5] ; Massimiliano,Bonifacio ^[6] ; Alice,Parisi ^[7] ; Valter,Gattei ^[2] ; Alberto,Zamò ^[8] ; Francesco,Mannelli ^[5] ; Andrés Celestino,García Montero ^[9] ; Roberta,Zanotti ^[6]

作者单位： Section of Hematology, Multidisciplinary Outpatients Clinics for Mastocytosis, Department of Medicine, AOUI, Verona, Italy.;Department of Immunohematology and Transfusion Medicine, ASST, Mantova, Italy. ^[1] Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, IRCCS, Aviano, Italy. ^[2] Section of Clinical Biochemistry, Department of Life and Reproduction Sciences, AOUI, Verona, Italy. ^[3] Department of Cell Therapy and Hematology, Ospedale San Bortolo, Vicenza, Italy. ^[4] Center of Research and Innovation of Myeloproliferative Neoplasms, Careggi University Hospital, Florence, Italy. ^[5] Section of Hematology, Multidisciplinary Outpatients Clinics for Mastocytosis, Department of Medicine, AOUI, Verona, Italy. ^[6] Department of Pathology, AOUI, Verona, Italy. ^[7] Department of Oncology, University of Turin, Turin, Italy. ^[8] Cancer Research Centre, Cytometry Service and Department of Medicine, University of Salamanca, Salamanca, Spain. ^[9]

关键词 D816V KIT mutation V617F JAK2 mutation myelodysplastic/myeloproliferative neoplasms ring sideroblasts systemic mastocytosis